Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4563366
Max Phase: Preclinical
Molecular Formula: C52H83N3O15
Molecular Weight: 990.24
Molecule Type: Unknown
Associated Items:
ID: ALA4563366
Max Phase: Preclinical
Molecular Formula: C52H83N3O15
Molecular Weight: 990.24
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](CC(C(=O)NC(C)(C)C)N(C)C(=O)c2ccccc2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@H]1O[C@@H](C)[C@H](O)[C@H](OC)[C@@H]1OC
Standard InChI: InChI=1S/C52H83N3O15/c1-15-39-35(27-66-51-47(65-14)46(64-13)43(60)32(6)68-51)23-28(2)21-22-37(56)29(3)24-34(25-36(48(62)53-52(7,8)9)55(12)49(63)33-19-17-16-18-20-33)45(30(4)38(57)26-40(58)69-39)70-50-44(61)41(54(10)11)42(59)31(5)67-50/h16-23,29-32,34-36,38-39,41-47,50-51,57,59-61H,15,24-27H2,1-14H3,(H,53,62)/b22-21+,28-23+/t29-,30+,31-,32+,34-,35-,36?,38-,39-,41+,42-,43+,44-,45-,46+,47+,50+,51+/m1/s1
Standard InChI Key: PJKFZJMDGMMOOT-OWRBHILOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 990.24 | Molecular Weight (Monoisotopic): 989.5824 | AlogP: 3.42 | #Rotatable Bonds: 14 |
Polar Surface Area: 232.32 | Molecular Species: NEUTRAL | HBA: 16 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.54 | CX Basic pKa: 7.94 | CX LogP: 3.85 | CX LogD: 3.20 |
Aromatic Rings: 1 | Heavy Atoms: 70 | QED Weighted: 0.17 | Np Likeness Score: 1.03 |
1. Budragchaa T, Westermann B, Wessjohann LA.. (2019) Multicomponent synthesis of α-acylamino and α-acyloxy amide derivatives of desmycosin and their activity against gram-negative bacteria., 27 (15): [PMID:31229422] [10.1016/j.bmc.2019.05.046] |
2. Budragchaa T, Westermann B, Wessjohann LA.. (2019) Multicomponent synthesis of α-acylamino and α-acyloxy amide derivatives of desmycosin and their activity against gram-negative bacteria., 27 (15): [PMID:31229422] [10.1016/j.bmc.2019.05.046] |
Source(1):